Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-2576Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-07-30 / BMC Cancer 2014 Jul;14:551γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.
/in Dendritic Cells, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3062)Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-05-12 / Virol. J. 2014 May;11:84Current status of oncothermia therapy for lung cancer
/in Hyperthermia, International Publications, NSCLC /von 2014-04-10 / Korean J Thorac Cardiovasc Surg 2014 Apr;47(2):77-93Immunotherapy in lung cancer
/in International Publications, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63Immunotherapy prospects in the treatment of lung cancer and mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45Immunotherapy and lung cancer: current developments and novel targeted therapies
/in Dendritic Cells, International Publications, NSCLC /von 2014-01-01 / Immunotherapy 2014;6(11):1221-35Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
/in Dendritic Cells, International Publications, NSCLC /von 2013-11-05 / Autoimmunity 2014 Feb;47(1):46-56IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de